𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gene therapy in germany and in europe: regulatory issues

✍ Scribed by Klaus Cichutek; Ines Krämer

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
189 KB
Volume
2
Category
Article
ISSN
1087-8378

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulatory issues in cellular therapies
Regulatory issues in cellular therapies
✍ Adrian P. Gee 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Cellular and gene therapies offer considerable promise as new treatment modalities. The Food and Drug Administration has been developing strategies to regulate these rapidly evolving fields in a manner that sustains progress and also ensures minimization of potential risks. The death of a patient on

Insulin therapy in Europe
Insulin therapy in Europe
✍ Werner A. Scherbaum 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

The prevalence of type 1 diabetes is rising in all European countries, particularly in Scandinavia and the UK. Insulin therapy in Europe is strongly influenced by the results of the Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS), both of whi

Issues in antiemetic therapy
Issues in antiemetic therapy
✍ Barry R. Goldspiel; Gregory A. Curt 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB
Use of H19 regulatory sequences for targ
Use of H19 regulatory sequences for targeted gene therapy in cancer
✍ Patricia Ohana; Osaat Bibi; Imad Matouk; Carol Levy; Tatiana Birman; Ilana Ariel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 409 KB 👁 2 views

## Abstract We present a tumor gene therapy approach based on the use of regulatory sequences of the H19 gene that are differentially expressed between normal and cancer cells. We constructed expression vectors carrying the gene for the A fragment of diphtheria toxin (DT‐A) or herpes simplex virus